The aim of this study was to determine the relationship between the levels of selected inflammatory, pro-oxidant and antioxidant markers; initial KP metabolites; BDNF; and symptom severity of the different dimensions of schizophrenia: positive, negative, cognitive and depressive. The gene discussed is BDNF; the disease is schizophrenia.